9月16日全球新冠肺炎(COVID-19)疫情简报,确诊超3914万,日增再创新高,国外疫苗和药物研发均不顺利

2020-10-16 MedSci原创 MedSci原创

据Worldometers实时统计数据显示,截至北京时间10月16日07时30分,全球新冠肺炎(COVID-19)确诊病例达3914万例,新增391,652例至39,144,675例,再创新增记录。死

据Worldometers实时统计数据显示,截至北京时间10月16日07时30分,全球新冠肺炎COVID-19)确诊病例达3914万例,新增391,652例至39,144,675例,再创新增记录。死亡病例达110万例,新增5,981例至1,102,299例,康复29,355,315例,活动病例8,616,893例,其中重症危重症为70,870例。全球确诊病例超过10万例的国家增至44个,瑞典为最新一个超过10万的国家。此外,危地马拉、葡萄牙、哥斯达黎加和日本的确诊病例已经超过9万。昨日报道:10月15日全球新冠肺炎(COVID-19)疫情简报,确诊超3872万,群体免疫做法再现争议

世界卫生组织实时统计数据显示,截至欧洲中部时间10月15日15时53分(北京时间21时53分),全球报告新冠肺炎确诊病例较前一日增加336515例,全球确诊病例超3839万例,达38394169例;全球报告新冠肺炎死亡病例超108.9万,达1089047例,较前一日增加5297例。

英军核潜艇到访美国后35人感染新冠艇员曾违规前往脱衣舞俱乐部

据美国海军研究学会(USNI)网站10月14日报道,一名美国官员透露,在对美国海军东海岸战略导弹核潜艇中心进行港口访问之后,英国皇家海军的“警惕”号战略导弹核潜艇上35多名被检测出感染新冠病毒。
这名美国官员证实了此前英国媒体的报道,即潜艇艇员违反了为防止潜艇上出现疫情的隔离规定。此前英国媒体报道称,潜艇艇员离开了位于美国乔治亚州国王湾的海军潜艇基地,曾到过200英里(约322公里)之外的佛罗里达州的可可海滩(佛罗里达州著名景点)。
而另据英国《镜报》14日的报道,该潜艇停靠在佛罗里达州后,35名水兵前往了位于佛罗里达州和佐治亚州和的酒吧及脱衣舞俱乐部,随后相继新冠检测呈阳性。

礼来公司的LY-CoV555抗体疗法也暂停试验

美国制药企业礼来公司13日宣布,因潜在安全原因暂停一项新冠抗体疗法的临床试验。礼来公司的LY-CoV555抗体疗法3期临床试验于8月初启动。这种抗体是一种针对新冠病毒刺突蛋白的单克隆抗体,从美国一名早期新冠康复患者的血液样本中分离而来。礼来公司没有透露暂停试验的具体原因,表示试验的独立数据安全监控委员会建议暂停继续招募试验参与者。

拜登竞选阵营称有两人新冠检测呈阳性

拜登竞选阵营称有两人新冠检测呈阳性。美国民主党副总统候选人哈里斯助手新冠检测呈阳性,此前其助手新冠检测呈阳性。拜登竞选团队经理表示,哈里斯没有被要求隔离,但出于谨慎起见取消了整个周日的行程,将于10月19日重回竞选活动,维持虚拟活动日程安排。

全球第五例!美国首例!25岁男子两次感染新冠,第二次病情加重

北京时间10月13日,发表在《Lancet Infectious Diseases(柳叶刀 传染病)》上的一项新研究显示,美国内华达州一名25岁的男子先后两次感染新冠病毒,而且,在第二次感染后病情加重。

这是美国首例重新感染新冠病毒的确诊病例,也是全球报告的第五个已知病例。

这名25岁男子是美国内华达州Washoe县的居民,第一次感染是在2020年4月的社区检测中证实;第二次是出现症状后于2020年5月底至2020年6月在医院确诊。

这些发现表明,该患者在两次不同的情况下被遗传上不同的新冠病毒感染了两次。因此,以前暴露过新冠病毒的人不能保证完全免疫。无论以前是否诊断为新冠肺炎,都应该采取相同的预防措施,以避免感染新冠病毒。”

《柳叶刀》杂志称,该患者已提供书面同意发表该报告,而内华达大学Reno机构审查委员会则放弃伦理许可。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年,为了防范第二波疫情,会不会延长假期呢?<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗,中和抗体都不安全?现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强?甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
    2020-10-16 志明

    今年过年,为了防范第二波疫情,会不会延长假期呢?#新冠肺炎#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年,为了防范第二波疫情,会不会延长假期呢?<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗,中和抗体都不安全?现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强?甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年,为了防范第二波疫情,会不会延长假期呢?<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗,中和抗体都不安全?现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强?甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
    2020-10-17 lqvr
  4. [GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年,为了防范第二波疫情,会不会延长假期呢?<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗,中和抗体都不安全?现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强?甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年,为了防范第二波疫情,会不会延长假期呢?<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗,中和抗体都不安全?现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强?甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
    2020-10-16 ms4000000799709505

    注意预防

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年,为了防范第二波疫情,会不会延长假期呢?<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗,中和抗体都不安全?现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强?甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
    2020-10-16 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年,为了防范第二波疫情,会不会延长假期呢?<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗,中和抗体都不安全?现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强?甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
    2020-10-16 lovetcm

    疫苗,中和抗体都不安全?现在看来#雷尼替丁##枸橼酸铋#最强?甚至比#瑞德西韦#还有效!#新冠肺炎#

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年,为了防范第二波疫情,会不会延长假期呢?<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗,中和抗体都不安全?现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强?甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
    2020-10-16 ms5000001082989414

    新的一轮感觉要来了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年,为了防范第二波疫情,会不会延长假期呢?<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗,中和抗体都不安全?现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强?甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
  10. [GetPortalCommentsPageByObjectIdResponse(id=892418, encodeId=1a9789241869, content=今年过年,为了防范第二波疫情,会不会延长假期呢?<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=志明, createdTime=Fri Oct 16 10:30:52 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285929, encodeId=74fe1285929c2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87830, encryptionId=aa308e8307e, topicName=药物研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Oct 17 22:36:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892430, encodeId=1ca789243017, content=注意预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87fa5426430, createdName=ms4000000799709505, createdTime=Fri Oct 16 11:26:31 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028661, encodeId=8ee810286618e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 16 10:36:01 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892405, encodeId=abd189240548, content=疫苗,中和抗体都不安全?现在看来<a href='/topic/show?id=107b98826b4' target=_blank style='color:#2F92EE;'>#雷尼替丁#</a><a href='/topic/show?id=a78b1039e8c4' target=_blank style='color:#2F92EE;'>#枸橼酸铋#</a>最强?甚至比<a href='/topic/show?id=bfa968e24a1' target=_blank style='color:#2F92EE;'>#瑞德西韦#</a>还有效!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98826, encryptionId=107b98826b4, topicName=雷尼替丁), TopicDto(id=103978, encryptionId=a78b1039e8c4, topicName=枸橼酸铋), TopicDto(id=68724, encryptionId=bfa968e24a1, topicName=瑞德西韦), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Oct 16 09:49:41 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892391, encodeId=f1a789239148, content=新的一轮感觉要来了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f935422938, createdName=ms5000001082989414, createdTime=Fri Oct 16 09:18:12 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892376, encodeId=e39e8923e669, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>加剧, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Oct 16 08:13:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892374, encodeId=c9588923e414, content=看过, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/1f0d3a1b1b18443fa30de1daf0223787/f02372391ce2429baba98d30608a173e.jpg, createdBy=1b362235963, createdName=内科, createdTime=Fri Oct 16 07:46:13 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
    2020-10-16 内科

    看过

    0

相关资讯

10月14日全球新冠肺炎(COVID-19)疫情简报,确诊超3831万,著名球星C罗也感染,儿童临床试验也开始

据称Worldometers实时统计数据显示,截至北京时间10月14日06时50分,全球新冠肺炎(COVID-19)确诊病例达3831万例,新增282,782例至38,317,481例,死亡病例近10

10月15日全球新冠肺炎(COVID-19)疫情简报,确诊超3872万,群体免疫做法再现争议

Worldometers世界实时统计数据显示,截至北京时间10月15日7时40分,全球新冠肺炎(COVID-19)累计确诊病例超过3872万例,达到38,723,568例,累计死亡病例超过109.6万

NEJM:新冠肺炎呼吸衰竭患者的遗传特征研究

本研究发现3p21.31基因簇是Covid-19呼吸衰竭患者的遗传易感性位点,并证实了ABO血型系统与新冠肺炎易感之间的关系

NEJM:核苷修饰RNA候选疫苗BNT162b1,BNT162b2用于新冠肺炎的预防

在针对美国中青及老年人群的研究中,核苷修饰RNA候选疫苗BNT162b2表现出良好的安全性及免疫原性

NEJM:mRNA-1273新冠肺炎疫苗对非人灵长类动物的保护作用

mRNA-1273可诱导非人灵长类动物产生较强的SARS-CoV-2中和活性,对上、下呼吸道有快速保护作用,肺部无病理变化

10月13日全球新冠肺炎(COVID-19)疫情简报,确诊病例突破3802万,中国新冠疫苗开放预约接种

据称Worldometers实时统计数据显示,截至北京时间10月13日06时58分,全球新冠肺炎(COVID-19)确诊病例达3802万例,添加244290例至38,022,478例,死亡病例达108